Jeffrey S. Weinberg

Preserving Continuity of Cancer Therapy in Patients with Hematologic Malignancies and Chronic Subdural Hematomas: Comparative Outcomes of Middle Meningeal Artery Embolization and Surgery

Esteban Ramírez Ferrer, Juan Pablo Zuluaga-García, María Alejandra Sierra, Danielle Hammond et autres

us, co (code pays fourni par la source)

Beyond motor: clinical manifestations of right hemisphere gliomas — a systematic review

Esteban Ramírez Ferrer, Kyle R. Noll, Juliana Mayorga-Corvacho, María Alejandra Sierra et autres

us, co, fr (code pays fourni par la source)

Intraoperative technological advances and new frontiers in precision glioma surgery

Christina Abi Faraj, Christopher C. Young, Thomas H. Beckham, Jeffrey S. Weinberg

us (code pays fourni par la source)

Supplementary Table S15 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips et autres

Supplementary Figure S4 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips et autres

Supplementary Table S19 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips et autres

Supplementary Table S12 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips et autres

Supplementary Table S4 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips et autres

Supplementary Table S11 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips et autres

Supplementary Table S29 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips et autres

Supplementary Table S22 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips et autres

Supplementary Figure S5 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips et autres